Arcturus Therapeutics Holdings Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Arcturus Therapeutics Holdings Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Arcturus Therapeutics Holdings Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $109M, a 10.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $109M +$10.2M +10.3% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $98.6M -$999K -1% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $99.6M +$54.3M +120% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $45.3M +$28.1M +163% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $17.2M +$6.69M +63.5% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $10.5M Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.